May 20, 2025 – Houston, TX — Noninvasix, a clinical-stage medical technology company pioneering noninvasive monitoring solutions for critically ill patients, is pleased to announce its participation in the 32nd Annual Medical Device & Digital Health Conference, hosted by Wilson Sonsini Goodrich & Rosati. The conference will take place on June 5–6, 2025, at the InterContinental Hotel in San Francisco, California.
This premier event brings together innovators, investors, and industry leaders to discuss critical topics shaping the future of medical technology and digital health. The 2025 agenda includes sessions on AI trends in healthcare, regulatory updates, commercialization strategies, and venture capital investments.
Noninvasix CEO David Giarracco will present the company’s latest advancements in its LIVOxMonitor, an optoacoustic platform designed to noninvasively measure arterial oxygen saturation (SaO₂) in real time, regardless of skin pigmentation. This technology aims to improve early detection and management of conditions like sepsis, offering more accurate and equitable oxygenation data at the point of care.
“We are honored to participate in Wilson Sonsini’s 2025 conference and engage with fellow innovators and investors committed to advancing patient care through technology,” said Giarracco. “Our LIVOx Monitor represents a significant step forward in noninvasive monitoring, and we look forward to sharing our progress and exploring new partnerships.”
To learn more about Noninvasix and schedule a meeting during the conference, please contact info@noninvasix.com.
About Noninvasix
Based in Houston, TX, Noninvasix is developing noninvasive optoacoustic monitoring technologies to support earlier diagnosis and more personalized treatment of sepsis and other critical conditions. Its proprietary platform enables real-time SaO₂ monitoring in deep vessels with accuracy across all skin tones—a key advancement over traditional pulse oximetry.
About the Medical Device & Digital Health Conference
Hosted by Wilson Sonsini Goodrich & Rosati, the annual Medical Device & Digital Health Conference is a leading forum for executives, investors, and innovators in the medtech and digital health sectors. The event addresses topics of critical importance to medical device and digital health companies, including regulatory updates, investment trends, and commercialization strategies.